KMT2A and acute lymphoblastic leukemia: Previous reports supported the involvement of SFKs in treatment resistance of MLL-ALL cells to GCs by showing that inhibition of SFKs prevented and reversed GC-resistance in MLL-ALL cells in vitro [20,21,24].